Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study
Patrizia Giannatempo, Daniele Raggi, Laura Marandino, Marco Bandini, Elena Farè, Giuseppina Calareso, Maurizio Colecchia, Andrea Gallina, Jeffrey S. Ross, Alessandra Alessi, Alberto Briganti, Francesco Montorsi, Russell W. Madison, Andrea Necchi
Topics & Concepts
MedicineMetastatic Urothelial CarcinomaInterimPembrolizumabSalvage therapyNab-paclitaxelOncologyPaclitaxelOpen labelUrothelial carcinomaInternal medicineChemotherapySurgeryImmunotherapyClinical trialCancerHistoryArchaeologyBladder cancerBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersRenal cell carcinoma treatment